Miglitol | 2335

An α-glucosidase inhibitor which induces an enhanced and prolonged release of glucagon-like peptide-1, regulating appetite and stabilizing body weight in humans. Displays anti-atherothrombotic effect by reducing platelet activation and raising circulating adiponectin levels in patients with type 2 diabetes. Clinically useful antidiabetic agent.

Miglitol is an α-glucosidase inhibitor which induces an enhanced and prolonged release of glucagon-like peptide-1, regulating appetite and stabilizing body weight in humans

2335 | Miglitol DataSheet

Alternate Name/Synonyms: (2R,3R,4R,5S)-1-(2-Hydroxyethyl)-2-(-(hydroxymethyl)piperidine-3,4,5-triol; N-(2-Hydroxyethyl)-1-deoxynojirimycin; BAY-1099

Appearance: White solid

Formulation: N/A

CAS Number: 72432-03-2

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₈H₁₇NO₅

Molecular Weight: 207.22

Cell-Permeable?: No

Purity: ≥98% by TLC

Solubilities: DMSO (50 mg/ml) or H2O (60 mg/ml)

Handling: Protect from moisture

Country of Origin: USA

Tag Line: An α-glucosidase inhibitor

MDL Number: N/A

PubChem CID: 441314

SMILES: C1C(C(C(C(N1CCO)CO)O)O)O

InChi: InChI=1S/C8H17NO5/c10-2-1-9-3-6(12)8(14)7(13)5(9)4-11/h5-8,10-14H,1-4H2/t5-,6+,7-,8-/m1/s1

InChi Key: IBAQFPQHRJAVAV-ULAWRXDQSA-N